Home » Topics » Drugs » Immuno-oncology

Immuno-oncology
RSS

Two additional U.S. patents allowed for Maxamine technology

Feb. 3, 2000

Biomira reports survival data for therapeutic cancer vaccine

Jan. 31, 2000

Progenics receives payment from BMS for cancer vaccine collaboration

Jan. 31, 2000

Immunomedics reports clinical findings for cancer therapeutic

Jan. 28, 2000

Biomira initiates next stage of phase II testing of BLP25/liposomal IL-2

Jan. 26, 2000

Neurocrine Biosciences updates clinical progress with IL-4 fusion toxin

Jan. 21, 2000

Avax Technologies' O-Vax IND accepted

Jan. 19, 2000

Oxford BioMedica acquires novel antibody technology

Jan. 17, 2000

AltaRex in-licenses antibody from NIH for AIT platform

Jan. 14, 2000

Ligand sells Marathon assets to CoPharma

Jan. 14, 2000

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 15, 2026.
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 14, 2026
Selective CBL-B inhibitor with improved safety profile disclosed
BioWorld Science
CBL-B is a RING-type E3 ubiquitin ligase that acts as a negative regulator of T-cell activation, contributing to immune homeostasis by limiting excessive immune...
MSD discloses new HCN1/2 blockers
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...